Literature DB >> 4018775

Pathologic study of parathyroid glands in tertiary hyperparathyroidism.

M W Krause, C E Hedinger.   

Abstract

Tertiary hyperparathyroidism is defined as persistent parathyroid hyperfunction developing from the secondary hyperplasia that occurs after restoration of renal function by dialysis or kidney transplantation. Controversy continues as to whether parathyroid adenoma or hyperplasia accounts for the autonomous hyperfunction. A review of 128 parathyroids from 41 patients with tertiary hyperparathyroidism revealed marked hyperplasia in 39 patients (95 per cent), with a predominance of chief cells, an abundance of oxyphil cells, and 10- to 40-fold increases in parathyroid mass. This hyperplasia was considered to be the predominant morphologic feature of tertiary hyperparathyroidism. Adenomas, found only in two patients (5 per cent), seem to be rare. Diffuse, moderately enlarged hyperplastic glands were found predominantly in patients with transplants, whereas nodular, markedly enlarged hyperplastic parathyroids were observed more frequently in patients treated by dialysis. In spite of the different patterns of hyperplasia and the different gland sizes in these two groups of patients, the grades of hypercalcemia were similar. The results of ultrastructural studies indicate that the majority of parenchymal cells in diffuse, and some cellular areas in nodular, hyperplasia may consist of cells with high secretory activity that do not respond normally to hypercalcemia. It is concluded that both increased parenchymal mass and cellular differentiation, leading to hyperactivity, account for tertiary hyperparathyroidism.

Entities:  

Mesh:

Year:  1985        PMID: 4018775     DOI: 10.1016/s0046-8177(85)80248-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

1.  Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation.

Authors:  C H Wallfelt; R Larsson; E Gylfe; S Ljunghall; J Rastad; G Akerström
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. I. Morphologic studies for tissue selection].

Authors:  B Niederle; H Hörandner; R Roka; W Woloszczuk
Journal:  Langenbecks Arch Chir       Date:  1988

3.  Coeliac disease and primary hyperparathyroidism: an association?

Authors:  M J Maida; E Praveen; S R Crimmins; G L Swift
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 4.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

5.  Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma.

Authors:  Peter F Nichol; James R Starling; Eberhard Mack; Jason J Klovning; Bryan N Becker; Herbert Chen
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

6.  Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and 123I for localization of rapid washout parathyroid adenomas.

Authors:  Y S Kushchayeva; S H Tella; S V Kushchayev; D Van Nostrand; K Kulkarni
Journal:  Osteoporos Int       Date:  2019-01-31       Impact factor: 4.507

7.  Graft-dependent renal hyperparathyroidism despite successful kidney transplantation.

Authors:  K Schlosser; M Rothmund; K Maschuw; P J Barth; T P Vahl; K L Suchan; E Domínguez Fernández
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

8.  Proliferation of endothelial component of parathyroid gland in multiple endocrine neoplasia type 1. Potential relationship with a mitogenic factor.

Authors:  T D'Adda; A Amorosi; G Bussolati; M L Brandi; C Bordi
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Authors:  N Fukuda; H Tanaka; Y Tominaga; M Fukagawa; K Kurokawa; Y Seino
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 10.  The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism.

Authors:  L Grimelius; G Akerström; L Bondeson; C Juhlin; H Johansson; S Ljunghall; J Rastad
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.